Jon Davis, MD
Dermatology · Evansville, INNPI 1053549139
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 452 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 27.2% of the total. Reporting peaked in 2021 at $1,467 and has fallen 68.7% since, to $459 in 2025.
Across 452 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Novartis$741
- E.r. Squibb & Sons, L.L.C.$523
- Sun Pharmaceutical Industries Inc.$511
- Lilly USA, LLC$314
- plus $2K from 24 others
Across 8 payments — averaging $713.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$6K
What the payments were for
- Food & beverage$7,31298%
- Education$1602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 134 | $2,032 |
| Johnson & Johnson | 75 | $1,036 |
| Novartis | 43 | $741 |
| E.r. Squibb & Sons, L.L.C. | 18 | $523 |
| Sun Pharmaceutical Industries Inc. | 30 | $511 |
| Lilly USA, LLC | 18 | $314 |
| Sanofi | 16 | $312 |
| Regeneron Healthcare Solutions, Inc. | 16 | $259 |
| Amgen | 13 | $249 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $215 |
| UCB, Inc. | 10 | $180 |
| LEO Pharma Inc. | 11 | $167 |
| Pfizer | 10 | $140 |
| Arcutis Biotherapeutics, Inc. | 8 | $125 |
| Incyte Corporation | 5 | $80 |
| Chiesi USA, Inc. | 2 | $78 |
| Boehringer Ingelheim | 4 | $71 |
| Genentech USA, Inc. | 4 | $62 |
| Galderma Laboratories, L.p. | 3 | $62 |
| Krystal Biotech Inc | 3 | $61 |
| Organogenesis Inc. | 3 | $54 |
| Dermavant Sciences, Inc. | 3 | $44 |
| VYNE Pharmaceuticals Inc. | 2 | $39 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Prugen, Inc. Pharmaceuticals | 2 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Biofrontera Inc. | 1 | $18 |
| Merck | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotyktu$141
How this compares
$7,473 in reported general payments places this provider in the 65th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 156 | $6,782 |
| Clobetasol Propionate | 118 | $6,245 |
| Ivermectin | 12 | $3,623 |
| Fluorouracil | 53 | $3,563 |
| Triamcinolone Acetonide | 298 | $3,350 |
| Pimecrolimus | 11 | $2,976 |
| Tretinoin | 17 | $2,700 |
| Doxycycline Hyclate | 190 | $2,663 |
| Metronidazole | 40 | $2,135 |
| Clindamycin Phosphate | 44 | $1,306 |
| Hydrocortisone | 130 | $1,067 |
| Ammonium Lactate | 61 | $1,031 |
| ValacyclovirValacyclovir Hcl | 53 | $875 |
| Doxycycline Monohydrate | 44 | $691 |
| Desonide | 14 | $632 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Evansville
- Charles HudsonEvansville$92K
- Thomas SelbyEvansville$15K
- Celine MestelEvansville$11K
- Jamie MullEvansville$10K
- Karl StaserEvansville$9K
- Dylan GreeneyEvansville$8K
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.